| D01071 | |
| D number | D01071 |
| Classification | Drug |
| Name | Hexobarbital (JAN/INN) |
| Component | - |
| Formula | C12H16N2O3 |
| Exact mass | 236.1161 |
| Mol weight | 236.267 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Neuropsychiatric agent DG01837 Barbiturate sedative-hypnotics DG01567 GABA-A receptor agonist DG02030 Anesthetics DG02027 General anesthetics DG02025 Barbiturate anesthetics DG02027 General anesthetics DG02025 Barbiturate anesthetics DG02025 Barbiturate anesthetics Cyp substrate DG01639 CYP2C19 substrate |
| Remark | Same as: C11723 ATC code: N01AF02 N05CA16 |
| Activity | - |
| Disease | - |
| Comment | Barbiturates |
| Target | GABRA/GABRB/GABRD/GABRE/GABRG/GABRP/GABRQ [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192] |
| Metabolism | Enzyme: CYP2C9 [HSA:1559], CYP2C19 [HSA:1557] |
| Interaction | |
| Other DBs | CAS: 56-29-1 PubChem: 7848134 ChEBI: 5706 ChEMBL: CHEMBL7728 DrugBank: DB01355 LigandBox: D01071 NIKKAJI: J1.915A |
| KCF data | - |